Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression
about
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseEvolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.Modelling the course of an HIV infection: insights from ecology and evolutionOrigin of the transmitted virus in HIV infection: infected cells versus cell-free virusThe Evolutionary Dynamics of a Rapidly Mutating Virus within and between Hosts: The Case of Hepatitis C VirusHIV and antiretroviral therapy in the brain: neuronal injury and repairEscape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness lossMaraviroc: the evidence for its potential in the management of HIVAssessing predicted HIV-1 replicative capacity in a clinical settingHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageHIV-1 Genetic Variability and Clinical ImplicationsPAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data.Understanding the slow depletion of memory CD4+ T cells in HIV infection.Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression.Latent coinfection and the maintenance of strain diversity.Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.Using genomic signatures for HIV-1 sub-typing.Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rateInitial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence.HIV-1 Transmission, Replication Fitness and Disease Progression.The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.Impaired replication capacity of acute/early viruses in persons who become HIV controllers.A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness.High viral fitness during acute HIV-1 infection.Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parametersRelative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.Evolution of virulence in emerging epidemics.HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression.The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.In vivo fitness associated with high virulence in a vertebrate virus is a complex trait regulated by host entry, replication, and shedding.Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.
P2860
Q21131580-F9296186-F8ED-42F4-A17C-1BF1E6D00A12Q24815687-49C528A9-0F1B-4F4B-BBBF-CCCDA8924AA9Q26853307-34D72810-6D79-4130-8D4A-F6450FC0BFAFQ27021279-6948FE24-B28B-469E-94A0-F08072A1C170Q27490256-E50DE3FD-36C9-4795-8E9C-8F82E5FF24E7Q28279808-06371392-1C74-47B4-8468-DB34D6E7E99DQ28469223-5532629F-0DA6-4E9C-BE7B-5628C24F4A6EQ28476655-4C27F48F-47CF-4CF2-B409-1D75042223FFQ28477801-A5B81451-7472-4B77-A0FB-AA599D17DE4BQ28487168-5A6B4999-F481-4C00-A4C8-485CE6ED20C6Q30278577-E0C72FDB-72ED-4A5E-A9D3-AB3B1867AB6CQ30352010-83FA9C56-3FFA-4277-A151-ECBD1FC8151FQ30788601-E10DD4AE-E7F5-42FE-933B-F233BBCD9412Q33285394-8DC2E83D-0CC9-4619-9E51-07F5EFADE02DQ33392723-FFEAA5A6-9AF4-41E4-ABFA-C95AE98C896AQ33392974-1002926D-E6F7-4B4D-994D-D07E83A295CDQ33399724-F5BDA724-4B62-427C-B1C0-7D8D937A5FF1Q33509024-40700A6E-7549-4730-B69B-720BB063BE1AQ33511235-61BC5758-8E79-4756-95C1-4602591FAC69Q33528199-8DC9BC65-6C56-4EF9-98FB-54AF919D6DCAQ33558599-812EE47D-4DA2-4006-B9AC-576AEEEBCC38Q33570433-BAC6CCC1-E46A-477E-8BF2-F70E8F3A3A15Q33758570-5A31E3C3-E265-4AE9-91B9-C89253582B48Q33884059-9834C842-324E-4429-8B66-5AD1F6EEFB24Q33963989-DB9642FF-073C-44CE-B877-2161916B0E64Q33980469-2DD1CE60-83F8-44BB-B4B5-09A53CB295ABQ34053505-30CC3A86-9851-43D7-BD9C-C9F817EE48C8Q34115280-E6D77C0D-54B6-4649-A128-75AFE31DBE32Q34178349-95FB19E8-B2B0-429D-BF31-155783A1C8D3Q34243486-C4251240-831C-46B2-992B-D6F8BD59FED2Q34367158-476BA6B8-5DA7-4767-8E3E-8DF379533ECBQ34629148-65ECF0D2-8092-4EC8-8751-583D679DC78AQ34653619-6312E703-DBFB-4F51-940B-A24CC8B8F1FCQ34719435-43DBD477-FF72-4E1B-8ED0-F9868774FEA8Q34806205-890268DC-318A-45F3-9B0F-2928C833AE35Q34885559-684BF382-87D0-4685-8DF7-6F1CC231E26FQ35022558-4C8C0AEA-8136-460D-B371-C352AF2A0A8EQ35076523-EB3E881F-5149-4729-A62E-0D455C33C368Q35127401-DDA35787-1415-492C-8C81-890AD70462D1Q35146589-DDDF0A9A-A1B3-49BF-8C64-A30918FFE56A
P2860
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Changes in human immunodeficie ...... ity during disease progression
@en
Changes in human immunodeficie ...... ty during disease progression.
@nl
type
label
Changes in human immunodeficie ...... ity during disease progression
@en
Changes in human immunodeficie ...... ty during disease progression.
@nl
prefLabel
Changes in human immunodeficie ...... ity during disease progression
@en
Changes in human immunodeficie ...... ty during disease progression.
@nl
P2093
P2860
P1433
P1476
Changes in human immunodeficie ...... ity during disease progression
@en
P2093
Awet Abraha
Dawn M Moore
Eric J Arts
Erika Fraundorf
Guido Vanham
James I Mullins
Kalonji R Collins
Mark A Jensen
Randall W Krizan
Robert L Colebunders
P2860
P304
P356
10.1128/JVI.79.14.9006-9018.2005
P407
P577
2005-07-01T00:00:00Z